UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 9, 2019
Accession Number:
Submission Type:
CIK:
0001444192
Company Name:
Acasti Pharma Inc.
File Number:
333-233063